Biophytis S.A. (BPTSY) Stock Analysis
DELISTED
What happened to Biophytis S.A. (BPTSY) stock?
Biophytis S.A. (BPTSY) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Biophytis S.A. (BPTSY). Biophytis S.A. is a clinical-stage biotechnology company focused on developing therapeutics for age-related diseases. Their lead drug candidate, BIO101, targets neuromuscular diseases and respiratory failure.
Last analyzed: Mar 16, 2026Biophytis S.A. (BPTSY) Healthcare & Pipeline Overview
Biophytis S.A. ADR Information Unsponsored
Biophytis S.A. (BPTSY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: BPTS
BPTSY OTC Market Information
BPTSY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy BPTSY shares?
No. BPTSY stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for BPTSY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BPTSY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Biophytis S.A.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.